Markets:

Overview

News

Currencies

International

Treasuries

Fulgent Genetics, Inc. - Common Stock (NQ:FLGT)

15.90 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 31, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Fulgent Genetics, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Fulgent Genetics Reports Fourth Quarter and Full Year 2021 Financial Results

February 23, 2022

From Fulgent Genetics, Inc.

Via Business Wire

The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development ↗

February 23, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase...

Via Benzinga

Fulgent Genetics to Announce Fourth Quarter and Full Year 2021 Financial Results on Wednesday February 23, 2022

February 14, 2022

From Fulgent Genetics, Inc.

Via Business Wire

The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow ↗

February 20, 2022

Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

January 03, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our...

Via Benzinga

Corona Doom 3.0: Omicron Surge. Profiting From The Boom In COVID-19 Testing Due To The Omicron Wave ↗

December 22, 2021

COVID testing in a parking garage in Miami on Tuesday (photo via Jordan Levin). Good Luck Getting Into A Medical Clinic A woman we know got in a car accident over the...

Via Benzinga

Corona Doom 3.0: Omicron Surge ↗

December 22, 2021

One of the beneficiaries of the COVID testing boom is Fulgent Genetics, Inc.

Via Talk Markets

5 Value Stocks In The Healthcare Sector ↗

December 20, 2021

What is a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...

Via Benzinga

Is Fulgent Genetics a Good Healthcare Stock to Buy? ↗

December 08, 2021

Shares fell earlier in the November, but popped again after a robust third-quarter earnings report.

Via The Motley Fool

HelioLiver™, an Innovative Liquid Biopsy Test for the Early Detection of Liver Cancer, is Now Commercially Available

December 06, 2021

From Fulgent Genetics, Inc.

Via Business Wire

How Wide Is Fulgent Genetics' Moat? ↗

December 03, 2021

The genetic testing company's moat is expanding.

Via The Motley Fool

3 Stocks That Could Make You Richer in December (and Beyond) ↗

December 02, 2021

Shares of these companies are gift-wrapped for those with patience.

Via The Motley Fool

Topics Economy

The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance ↗

December 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus U.K. Signs Deal to Buy Incremental COVID-19 Vaccines From Moderna And Pfizer-...

Via Benzinga

Jim Cramer Weighs In On Carnival, Canadian Pacific Railway And More ↗

December 02, 2021

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Fulgent Genetics, Inc. (NASDAQ:

Via Benzinga

Fulgent Genetics Confirms Ability to Detect Omicron Variant with RT-PCR Tests for COVID-19

December 01, 2021

From Fulgent Genetics, Inc.

Via Business Wire

56 Biggest Movers From Friday ↗

November 29, 2021

Gainers iSpecimen Inc. (NASDAQ: ISPC) climbed 71.7% to settle at $17.51 on Friday. The company recently announced it has been contracted to support new advanced research on...

Via Benzinga

Is Fulgent Genetics Undervalued? ↗

November 28, 2021

Whether Fulgent is a value or a value trap depends on the short-term prospects for COVID-19 and the long-term prospects for its core sequencing business.

Via The Motley Fool

48 Stocks Moving In Friday's Mid-Day Session ↗

November 26, 2021

Gainers Allied Healthcare Products, Inc. (NASDAQ: AHPI) shares jumped 68% to $9.04. Shares of mask and protective apparel companies, including Allied Healthcare Products, traded...

Via Benzinga

3 Small-Cap COVID Stocks With Huge Upside ↗

November 25, 2021

Three Fool.com contributors are bullish on Beyond Air, Ocugen, and Fulgent Genetics.

Via The Motley Fool

The Monster Business Lurking Behind Fulgent's COVID Results ↗

November 24, 2021

Fulgent's recent earnings report confirmed the strength of its core testing business.

Via The Motley Fool

A Look Into Healthcare Sector Value Stocks ↗

November 22, 2021

What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...

Via Benzinga

How Is Fulgent Genetics Staying Ahead of Its Competition? ↗

November 20, 2021

The key is by focusing on doctors.

Via The Motley Fool

What Investors Should Like About Fulgent Genetics' Q3 Results ↗

November 19, 2021

The genetic testing company delivered a solid performance in Q3.

Via The Motley Fool

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 10, 2021

Gainers Valneva (NASDAQ:VALN) shares increased by 24.51% to $50.34 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.6...

Via Benzinga

Fulgent Genetics Q3 Revenues More Than Double; Raises FY21 Outlook ↗

November 10, 2021

Fulgent Genetics Inc (NASDAQ: FLGT) reported Q3 sales of $227.9 million, +124% Y/Y, beating the consensus of $264 million primarily driven by sales of its COVID-19...

Via Benzinga

Fulgent Genetics, Inc. Common Stock (FLGT) Q3 2021 Earnings Call Transcript ↗

November 10, 2021

FLGT earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Fulgent Genetics: Q3 Earnings Insights ↗

November 09, 2021

Fulgent Genetics (NASDAQ:FLGT) reported its Q3 earnings results on Tuesday, November 9, 2021 at 04:00 PM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Fulgent Genetics Reports Third Quarter Financial Results

November 09, 2021

From Fulgent Genetics, Inc.

Via Business Wire

Representatives of Fulgent Genetics to Participate in Upcoming Virtual Conferences

November 09, 2021

From Fulgent Genetics, Inc.

Via Business Wire

The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data ↗

November 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.